Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Aduna telco network API JV breaks through traditional global contract hurdles, says GlobalData

Following the news that 12 global telcos have completed their equity investments in Ericsson subsidiary and 50:50 joint venture (JV) Aduna; Emma Mohr-McClune, Chief Analyst – Telecoms Practice, Technology at GlobalData, offers her view: “This JV, which first went operational in September 2024, marks a pivotal moment for the telecommunications industry. By uniting some of […]
Read more

Influencer sentiment soars as Tesla partners with Samsung for next-gen AI chip, reveals GlobalData

Tesla has emerged as a trending company among influencers on X, primarily due to its significant $16.5 billion contract with Samsung Electronics for the manufacturing of advanced semiconductors. This partnership marks a pivotal moment for both companies. For Tesla, it solidifies its position in the competitive electric vehicle (EV) and AI landscape, while for Samsung, […]
Read more

Hyundai’s Q2 2025 advertising campaigns showcase innovation, performance, and sustainability, reveals GlobalData

Hyundai’s YouTube advertising campaigns for Q2 2025 focus on promoting various models, including the IONIQ series, Palisade, and N Vision 74. The ads emphasize sustainability, performance, and community engagement, highlighting Hyundai’s commitment to eco-friendly technology and high-performance vehicles. This integrated approach not only showcases Hyundai’s automotive advancements but also aligns with evolving consumer expectations, reveals […]
Read more

Unitree Robotics’ launch of affordable humanoid robot sparks excitement among influencers on X, reveals GlobalData

Unitree Robotics has recently emerged as a trending topic among influencers on social media, largely due to the launch of its new low-cost humanoid robot, the R1, priced at around $5,900. This pricing strategy has drawn comparisons to DJI’s early market tactics, where undercutting competitors helps establish a dominant position. Influencers on “X” have noted […]
Read more

Biomarker identification to address unmet needs of idiopathic pulmonary fibrosis treatment, says GlobalData

Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal lung disease characterized by the accumulation of scar tissue in the lungs, leading to respiratory failure. The current treatment approaches for IPF include Boehringer Ingelheim’s Ofev (nintedanib) and Roche’s Esbriet (pirfenidone). However, current treatments may not address several unmet needs in this space, particularly regarding […]
Read more

Top 20 biopharmaceutical companies see 7.9% increase in aggregate revenue in 2024, reveals GlobalData

The biopharmaceutical industry had a positive year in 2024, with obesity drug developers continuing to witness success. Nearly all (19) of the top 20 players publicly traded global biopharmaceutical companies reported revenue growth in 2024, with an overall 7.9% year-on-year (YoY) increase in aggregate revenue to $880.4 billion, reveals GlobalData, a leading data analytics and […]
Read more

China’s obesity market poised for takeoff with homegrown therapies and late-stage pipeline, says GlobalData

China has recently approved the first locally developed obesity drug “Xinermei (mazdutide),” marking a critical milestone in the country’s obesity treatment landscape. Backed by a robust late-stage pipeline and differentiated dual-receptor mechanisms, the domestic obesity therapeutics market is set for rapid expansion, driven by innovation, rising disease burden, and a shift toward more accessible, locally […]
Read more

North America capsule endoscopy market to register 6.2% CAGR over 2024-34, forecasts GlobalData

Capsule endoscopy is a non-invasive approach that aids healthcare providers in diagnosing conditions such as gastrointestinal bleeding, Barrett’s oesophagus, inflammatory bowel disease (IBD), and other gastrointestinal disorders. Driven by growing demand for minimally invasive procedures, the capsule endoscopy market in North America is set to experience steady growth, registering a compound annual growth rate (CAGR) […]
Read more

World Hepatitis Day 2025: Renewed global push urgent need amid rising mortality, says GlobalData

World Hepatitis Day, observed each year on 28 July, highlights the urgent need to combat viral hepatitis—one of the world’s deadliest infectious diseases, impacting over 300 million people globally. Despite available vaccines and treatments, rising mortality and persistent systemic, financial, and social barriers underscore the critical importance of renewed global efforts toward hepatitis elimination by […]
Read more

Liquid risk forces insurers to reinvent operations and redefine protection, says Celent, a GlobalData company

In an era defined by continuous disruption and systemic uncertainty, the insurance industry stands at a pivotal moment. Traditional approaches to underwriting, pricing, and risk modelling are faltering in the face of climate change, technological disruption, geopolitical fragmentation, and social instability. Against this backdrop, the concept of Liquid Risk casts risk as dynamic, interconnected and […]
Read more

Semaglutide emerges as contender in cerebrovascular disease management, says GlobalData

Semaglutide, a GLP-1R agonist also known as Ozempic or Wegovy and initially developed for type 2 diabetes, is emerging as a promising candidate for neurological conditions. The recent clinical findings suggest its potential to improve outcomes in stroke and brain hemorrhage patients, driven by its cardiovascular and anti-inflammatory effects. These developments highlight a significant therapeutic […]
Read more
1 … 63 64 65 66 67 … 784